Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study

BACKGROUND: Frailty is rarely assessed in clinical trials of patients who receive dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. This study investigated whether frailty defined using claims data is associated with outcomes following percutaneous coronary intervention, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Faridi, Kamil F., Strom, Jordan B., Kundi, Harun, Butala, Neel M., Curtis, Jeptha P., Gao, Qi, Song, Yang, Zheng, Luke, Tamez, Hector, Shen, Changyu, Secemsky, Eric A., Yeh, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382113/
https://www.ncbi.nlm.nih.gov/pubmed/37449567
http://dx.doi.org/10.1161/JAHA.123.029588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382113/
https://www.ncbi.nlm.nih.gov/pubmed/37449567
http://dx.doi.org/10.1161/JAHA.123.029588

Ejemplares similares